We are live on
!
Find out more
CLOS
Compagnie Lombard Odier SCmA Portfolio holdings
AUM
$9.25B
1-Year Est. Return
27.04%
This Fund
S&P 500
This Quarter
Est. Return
+0.19%
1 Year Est. Return
+27.04%
3 Year Est. Return
+108.78%
5 Year Est. Return
+129.43%
10 Year Est. Return
+503.05%
AUM
$2.66B
AUM Growth
+$488M
(+23%)
Cap. Flow
+$467M
Cap. Flow
% of AUM
17.57%
Top 10 Holdings %
Top 10 Hldgs %
33.48%
Holding
999
New
227
Increased
320
Reduced
138
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$110M |
| 2 |
Mondelez International
MDLZ
|
+$27.5M |
| 3 |
Apple
AAPL
|
+$26.3M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$23.8M |
| 5 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$23.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Kokusai Fund
TOK
|
+$59.3M |
| 2 |
Gilead Sciences
GILD
|
+$56.8M |
| 3 |
eBay
EBAY
|
+$30.6M |
| 4 |
Medtronic
MDT
|
+$11.7M |
| 5 |
Amgen
AMGN
|
+$9.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.21% |
| 2 | Consumer Staples | 13.83% |
| 3 | Financials | 11.48% |
| 4 | Technology | 10.19% |
| 5 | Energy | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MJN
26
DELISTED
Mead Johnson Nutrition Company
MJN
| $28.7M | 1.08% |
285,131
+98,341
| +53% | +$9.92M |
|
27
Cisco
CSCO
$479B
| $28.5M | 1.07% |
1,034,718
+594,949
| +135% | +$16.7M |
|
28
Colgate-Palmolive
CL
$74.4B
| $27.7M | 1.04% |
399,927
-4,575
| -1% | -$316K |
|
29
McDonald's
MCD
$195B
| $27.2M | 1.02% |
279,357
+851
| +0.3% | +$80.7K |
|
30
Intel
INTC
$513B
| $24.5M | 0.92% |
784,119
+140,294
| +22% | +$4.73M |
|
31
ExxonMobil
XOM
$634B
| $23.9M | 0.9% |
280,624
+90,230
| +47% | +$8M |
|
|
TIF
32
DELISTED
Tiffany & Co.
TIF
| $23.8M | 0.89% |
269,940
+266,601
| +7,984% | +$23.8M |
|
33
Verizon
VZ
$196B
| $23.6M | 0.89% |
484,756
+174,461
| +56% | +$8.42M |
|
|
PX
34
DELISTED
Praxair Inc
PX
| $19.4M | 0.73% |
160,880
+57,230
| +55% | +$7.16M |
|
|
ADT
35
DELISTED
ADT Corp
ADT
| $18.5M | 0.7% |
444,837
+22,310
| +5% | +$837K |
|
36
Bristol-Myers Squibb
BMY
$132B
| $17.1M | 0.65% |
265,730
-1,341
| -0.5% | -$84K |
|
37
Pfizer
PFE
$153B
| $16.6M | 0.63% |
503,508
+248,155
| +97% | +$7.89M |
|
38
Microsoft
MSFT
$3.71T
| $16.5M | 0.62% |
406,605
+79,131
| +24% | +$3.44M |
|
|
UN
39
DELISTED
Unilever NV New York Registry Shares
UN
| $16.3M | 0.61% |
390,600
-7,590
| -2% | -$318K |
|
40
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.77B
| $15.2M | 0.57% |
238,095
+64,790
| +37% | +$4.07M |
|
|
KRFT
41
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $14.9M | 0.56% |
170,863
+41,456
| +32% | +$2.74M |
|
42
International Flavors & Fragrances
IFF
$21.9B
| $14.8M | 0.56% |
126,328
+59,272
| +88% | +$6.69M |
|
43
Chevron
CVX
$366B
| $14.3M | 0.54% |
135,866
+41,795
| +44% | +$4.46M |
|
44
Range Resources
RRC
$8.95B
| $13.9M | 0.52% |
266,555
+156,274
| +142% | +$7.75M |
|
45
Brookfield
BN
$108B
| $13.4M | 0.5% |
1,067,841
+597,991
| +127% | +$7.41M |
|
46
Kimberly-Clark
KMB
$36.5B
| $13M | 0.49% |
121,460
+1,460
| +1% | +$161K |
|
47
Invesco QQQ Trust
QQQ
$484B
| $12.5M | 0.47% |
117,984
+35,558
| +43% | +$3.73M |
|
48
CVS Health
CVS
$122B
| $12.4M | 0.47% |
120,340
+71,159
| +145% | +$7.2M |
|
49
Walmart Inc
WMT
$890B
| $12.4M | 0.47% |
450,999
+241,008
| +115% | +$6.84M |
|
50
EOG Resources
EOG
$70.7B
| $12.1M | 0.45% |
131,805
-15,941
| -11% | -$1.44M |
|
Similar funds
SUT
HKAM
LCAM
IAA
WPL
PVI
AC
SFM
Compagnie Lombard Odier SCmA's Q1 2015 Portfolio in Review
As of Q1 2015, Compagnie Lombard Odier SCmA held 999 positions worth $2.66B, up 23% from $2.17B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Compagnie Lombard Odier SCmA deployed $467M of net new capital in Q1 2015, opening 227 new positions and adding to 320 existing holdings. Its largest new stake was Discovery, Inc. Series C Common Stock: 355,000 shares worth $10.5M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Financials.
On the sell side, the largest reduction was iShares MSCI Kokusai Fund, an estimated $59.3M trimmed.
- Compagnie Lombard Odier SCmA's largest Q1 2015 buy was Discovery, Inc. Series C Common Stock: 355,000 shares worth $10.5M.
- Compagnie Lombard Odier SCmA added most to AbbVie in Q1 2015, an estimated $110M increase.
- Compagnie Lombard Odier SCmA's biggest Q1 2015 reduction was iShares MSCI Kokusai Fund, cutting an estimated $59.3M.
- Compagnie Lombard Odier SCmA fully exited Medtronic in Q1 2015, selling an estimated $11.7M.
- Compagnie Lombard Odier SCmA's ten largest holdings make up 33% of its $2.66B portfolio in Q1 2015.
- Compagnie Lombard Odier SCmA opened 227 new positions and closed 46 in Q1 2015.
- Compagnie Lombard Odier SCmA's portfolio value rose 23% quarter-over-quarter to $2.66B.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2015, filed 13 May 2015.